Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Douglas Richman

    TitleProfessor In Residence
    SchoolUniversity of California, San Diego
    DepartmentMedicine
    Address9500 Gilman Drive #0679
    CA La Jolla 92093
    Phone858-552-8585
    vCardDownload vCard

      Collapse Research 
      Collapse Research Activities and Funding
      Martin Delaney Collaboratory to Eradicate HIV-1 Infection
      NIH U19AI096113Jul 8, 2011 - Jun 30, 2016
      Role: Co-Investigator
      Gene expression biomarkers of immune recovery in HIV infected patients
      NIH/NIAID R01AI087164Dec 15, 2009 - Nov 30, 2014
      Role: Principal Investigator
      Targeting regulators of cellular gene transcription to impact HIV latency
      NIH/NIAID P01AI080193Jun 5, 2009 - Dec 31, 2011
      Role: Principal Investigator
      Determinants of HIV Transmission
      NIH/NIAID P01AI074621Mar 15, 2008 - Feb 28, 2014
      Role: Co-Investigator
      Meeting Support for HIV Dynamics and Evolution
      NIH/NIAID R13AI056338Apr 1, 2003 - Jul 31, 2011
      Role: Principal Investigator
      9th Annual International Mtg on HIV Dynamics &Evolution
      NIH/NIAID R13AI051989Mar 16, 2002 - Mar 15, 2003
      Role: Principal Investigator
      BIOMATHEMATICAL ANALYSIS OF VIRAL DYNAMICS AND EVOLUTION
      NIH/NIAID R01AI047745Jul 1, 2000 - Dec 31, 2011
      Role: Principal Investigator
      BIOMATHEMATICAL ANALYSIS OF VIRAL DYNAMICS AND EVOLUTION
      NIH/NIAID R21AI047745Jul 1, 2000 - Jun 30, 2001
      Role: Principal Investigator
      Southern California Primary Infection Program
      NIH/NIAID U01AI043638Aug 1, 1998 - Jun 30, 2011
      Role: Principal Investigator
      RESISTANCE TO ANTIVIRALS IN HIV INFECTED PATIENTS
      NIH/FIC R03TW000767Sep 30, 1996 - Feb 28, 2003
      Role: Principal Investigator
      ANTIVIRAL RESISTANCE IN AIDS
      NIH/FIC R03TW000680Sep 1, 1996 - Aug 31, 1999
      Role: Principal Investigator
      Center for AIDS Research
      NIH/NIAID P30AI036214Apr 1, 1994 - Mar 31, 2018
      Role: Principal Investigator
      AIDS Training Grant
      NIH/NIAID T32AI007384Aug 1, 1990 - Aug 31, 2021
      Role: Principal Investigator
      RAPID MICROBIAL DIAGNOSIS BY NUCLEIC ACID AMPLIFICATION
      NIH/NIAID U01AI030457Jul 1, 1990 - Jun 30, 1996
      Role: Principal Investigator
      ANTIVIRAL RESISTANCE IN AIDS
      NIH/NIAID R37AI029164Sep 30, 1989 - Jun 30, 2006
      Role: Principal Investigator
      MECHANISMS OF RESISTANCE IN CLINICAL ISOLATES OF HIV
      NIH/NIAID R01AI029164Sep 30, 1989 - Jul 31, 1994
      Role: Principal Investigator
      DEVELOPMENT OF SCREENING TESTS FOR HTLV-III
      NIH/NHLBI N01HB067019Sep 30, 1986 - Jun 1, 1992
      Role: Principal Investigator
      SAN DIEGO AIDS CLINICAL TRIAL UNIT
      NIH/NIAID U01AI027670Jun 30, 1986 - Dec 31, 2006
      Role: Principal Investigator
      NUCLEIC ACID HYBRIDIZATION TO DETECT AIDS RELATED AGENTS
      NIH/NHLBI R01HL032471Apr 1, 1984 - Mar 31, 1988
      Role: Principal Investigator

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Wensing AM, Calvez V, Günthard HF, Johnson VA, Paredes R, Pillay D, Shafer RW, Richman D. 2017 Update of the Drug Resistance Mutations in HIV-1. Top Antivir Med. 2017 Dec/Jan; 24(4):132-133. PMID: 28208121.
        View in: PubMed
      2. Benson CA, Currier JS, Del Rio C, Gallant JE, Gulick RM, Marrazzo JM, Richman D, Saag MS, Schooley RT, Volberding PA. A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care. Top Antivir Med. 2017 Dec/Jan; 24(4):142-151. PMID: 28208122.
        View in: PubMed
      3. Richman D, Gallo RC. Mark Wainberg. Curr Opin HIV AIDS. 2017 Sep; 12(5):423-424. PMID: 28771448.
        View in: PubMed
      4. Wagner GA, Landais E, Caballero G, Phung P, Kosakovsky Pond SL, Poignard P, Richman D, Little SJ, Smith DM. Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response. J Virol. 2017 Sep 01; 91(17). PMID: 28615205.
        View in: PubMed
      5. Beliakova-Bethell N, Hezareh M, Wong JK, Strain MC, Lewinski MK, Richman D, Spina CA. Relative efficacy of T cell stimuli as inducers of productive HIV-1 replication in latently infected CD4 lymphocytes from patients on suppressive cART. Virology. 2017 Aug; 508:127-133. PMID: 28527342.
        View in: PubMed
      6. Yek C, Massanella M, Peling T, Lednovich K, Nair SV, Worlock A, Vargas M, Gianella S, Ellis RJ, Strain MC, Busch MP, Nugent CT, Richman D. Evaluation of the Aptima HIV-1 Quant Dx Assay for HIV-1 RNA Quantitation in Different Biological Specimen Types. J Clin Microbiol. 2017 Aug; 55(8):2544-2553. PMID: 28592548.
        View in: PubMed
      7. Choi JY, Pond SLK, Anderson CM, Richman D, Smith DM. Molecular Features of the V1-V4 Coding Region of Sexually Transmitted Human Immunodeficiency Virus Type 1. J Infect Dis. 2017 May 15; 215(10):1506-1513. PMID: 28419276.
        View in: PubMed
      8. Vesa J, Chaillon A, Wagner GA, Anderson CM, Richman D, Smith DM, Little SJ. Increased HIV-1 superinfection risk in carriers of specific human leukocyte antigen alleles. AIDS. 2017 May 15; 31(8):1149-1158. PMID: 28244954.
        View in: PubMed
      9. Honeycutt JB, Thayer WO, Baker CE, Ribeiro RM, Lada SM, Cao Y, Cleary RA, Hudgens MG, Richman D, Garcia JV. HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy. Nat Med. 2017 May; 23(5):638-643. PMID: 28414330.
        View in: PubMed
      10. Richman D. HIV: Finding latent needles in a haystack. Nature. 2017 03 23; 543(7646):499-500. PMID: 28297707.
        View in: PubMed
      11. White CH, Moesker B, Beliakova-Bethell N, Martins LJ, Spina CA, Margolis DM, Richman D, Planelles V, Bosque A, Woelk CH. Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model. PLoS Pathog. 2016 Nov; 12(11):e1006026. PMID: 27898737.
        View in: PubMed
      12. Wagner GA, Chaillon A, Liu S, Franklin DR, Caballero G, Kosakovsky Pond SL, Vaida F, Heaton RK, Letendre SL, Grant I, Richman D, Smith DM. HIV-associated neurocognitive disorder is associated with HIV-1 dual infection. AIDS. 2016 Nov 13; 30(17):2591-2597. PMID: 27536983.
        View in: PubMed
      13. Karris MY, Umlauf A, Vaida F, Richman D, Little S, Smith D. A randomized controlled clinical trial on the impact of CCR5 blockade with maraviroc in early infection on T-cell dynamics. Medicine (Baltimore). 2016 Nov; 95(44):e5315. PMID: 27858912.
        View in: PubMed
      14. Bruner KM, Murray AJ, Pollack RA, Soliman MG, Laskey SB, Capoferri AA, Lai J, Strain MC, Lada SM, Hoh R, Ho YC, Richman D, Deeks SG, Siliciano JD, Siliciano RF. Defective proviruses rapidly accumulate during acute HIV-1 infection. Nat Med. 2016 Sep; 22(9):1043-9. PMID: 27500724; NIHMSID: NIHMS800456 [Available on 03/01/17].
        View in: PubMed
      15. Lee SA, Bacchetti P, Chomont N, Fromentin R, Lewin SR, O'Doherty U, Palmer S, Richman D, Siliciano JD, Yukl SA, Deeks SG, Burbelo PD. Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy. PLoS One. 2016; 11(8):e0160192. PMID: 27483366.
        View in: PubMed
      16. Deeks SG, Lewin SR, Ross AL, Ananworanich J, Benkirane M, Cannon P, Chomont N, Douek D, Lifson JD, Lo YR, Kuritzkes D, Margolis D, Mellors J, Persaud D, Tucker JD, Barre-Sinoussi F. International AIDS Society global scientific strategy: towards an HIV cure 2016. Nat Med. 2016 Aug; 22(8):839-50. PMID: 27400264.
        View in: PubMed
      17. Mehta SR, Murrell B, Anderson CM, Kosakovsky Pond SL, Wertheim JO, Young JA, Freitas L, Richman D, Mathews WC, Scheffler K, Little SJ, Smith DM. Using HIV Sequence and Epidemiologic Data to Assess the Effect of Self-referral Testing for Acute HIV Infection on Incident Diagnoses in San Diego, California. Clin Infect Dis. 2016 Jul 1; 63(1):101-7. PMID: 27174704.
        View in: PubMed
      18. Gianella S, Anderson CM, Var SR, Oliveira MF, Lada SM, Vargas MV, Massanella M, Little SJ, Richman D, Strain MC, Pérez-Santiago J, Smith DM. Replication of Human Herpesviruses Is Associated with Higher HIV DNA Levels during Antiretroviral Therapy Started at Early Phases of HIV Infection. J Virol. 2016 Apr 15; 90(8):3944-52. PMID: 26842469.
        View in: PubMed
      19. Richman D. Editorial Commentary: HIV Is Putting Up Less Resistance. Clin Infect Dis. 2016 May 15; 62(10):1318-9. PMID: 26962077.
        View in: PubMed
      20. Panichsillapakit T, Smith DM, Wertheim JO, Richman D, Little SJ, Mehta SR. Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996-2013. J Acquir Immune Defic Syndr. 2016 Feb 1; 71(2):228-36. PMID: 26413846.
        View in: PubMed
      21. Massanella M, Richman D. Measuring the latent reservoir in vivo. J Clin Invest. 2016 Feb 1; 126(2):464-72. PMID: 26829625.
        View in: PubMed
      22. Panichsillapakit T, Patel D, Santangelo J, Richman D, Little SJ, Smith DM. Colorectal Disorders in Acute Human Immunodeficiency Virus Infection: A Case Series. Open Forum Infect Dis. 2016 Jan; 3(1):ofw014. PMID: 26925432.
        View in: PubMed
      23. Rhee SY, Jordan MR, Raizes E, Chua A, Parkin N, Kantor R, Van Zyl GU, Mukui I, Hosseinipour MC, Frenkel LM, Ndembi N, Hamers RL, Rinke de Wit TF, Wallis CL, Gupta RK, Fokam J, Zeh C, Schapiro JM, Carmona S, Katzenstein D, Tang M, Aghokeng AF, De Oliveira T, Wensing AM, Gallant JE, Wainberg MA, Richman D, Fitzgibbon JE, Schito M, Bertagnolio S, Yang C, Shafer RW. HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing. PLoS One. 2015; 10(12):e0145772. PMID: 26717411.
        View in: PubMed
      24. Richman D. HIV: Cure by killing. Nature. 2015 Dec 10; 528(7581):198-9. PMID: 26633623.
        View in: PubMed
      25. Gianella S, Anderson CM, Richman D, Smith DM, Little SJ. No evidence of posttreatment control after early initiation of antiretroviral therapy. AIDS. 2015 Oct 23; 29(16):2093-7. PMID: 26544575.
        View in: PubMed
      26. Wensing AM, Calvez V, Günthard HF, Johnson VA, Paredes R, Pillay D, Shafer RW, Richman D. 2015 Update of the Drug Resistance Mutations in HIV-1. Top Antivir Med. 2015 Oct-Nov; 23(4):132-41. PMID: 26713503.
        View in: PubMed
      27. White CH, Johnston HE, Moesker B, Manousopoulou A, Margolis DM, Richman D, Spina CA, Garbis SD, Woelk CH, Beliakova-Bethell N. Mixed effects of suberoylanilide hydroxamic acid (SAHA) on the host transcriptome and proteome and their implications for HIV reactivation from latency. Antiviral Res. 2015 Nov; 123:78-85. PMID: 26343910.
        View in: PubMed
      28. Massanella M, Gianella S, Schrier R, Dan JM, Pérez-Santiago J, Oliveira MF, Richman D, Little SJ, Benson CA, Daar ES, Dube MP, Haubrich RH, Smith DM, Morris SR. Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy. Sci Rep. 2015; 5:13179. PMID: 26299251.
        View in: PubMed
      29. Procopio FA, Fromentin R, Kulpa DA, Brehm JH, Bebin AG, Strain MC, Richman D, O'Doherty U, Palmer S, Hecht FM, Hoh R, Barnard RJ, Miller MD, Hazuda DJ, Deeks SG, Sékaly RP, Chomont N. A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals. EBioMedicine. 2015 Aug; 2(8):872-81. PMID: 26425694.
        View in: PubMed
      30. Massanella M, Gianella S, Lada SM, Richman D, Strain MC. Quantification of Total and 2-LTR (Long terminal repeat) HIV DNA, HIV RNA and Herpesvirus DNA in PBMCs. Bio Protoc. 2015 Jun 5; 5(11). PMID: 27478862.
        View in: PubMed
      31. Abdel-Mohsen M, Wang C, Strain MC, Lada SM, Deng X, Cockerham LR, Pilcher CD, Hecht FM, Liegler T, Richman D, Deeks SG, Pillai SK. Select host restriction factors are associated with HIV persistence during antiretroviral therapy. AIDS. 2015 Feb 20; 29(4):411-20. PMID: 25602681.
        View in: PubMed
      32. Okulicz JF, Le TD, Agan BK, Camargo JF, Landrum ML, Wright E, Dolan MJ, Ganesan A, Ferguson TM, Smith DM, Richman D, Little SJ, Clark RA, He W, Ahuja SK. Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals. JAMA Intern Med. 2015 Jan 1; 175(1):88-99. PMID: 25419650.
        View in: PubMed
      33. Torbett BE, Goodsell DS, Richman D. Preface. Curr Top Microbiol Immunol. 2015; 389:v-vii. PMID: 26086053.
        View in: PubMed
      34. Massanella M, Ouchi D, Marfil S, Llibre JM, Puertas MC, Buzón MJ, Richman D, Orna E, Stevenson M, Gatell JM, Domingo P, Negredo E, Martinez-Picado J, Clotet B, Blanco J. Different Plasma Markers of Inflammation Are Influenced by Immune Recovery and cART Composition or Intensification in Treated HIV Infected Individuals. PLoS One. 2014; 9(12):e114142. PMID: 25462535.
        View in: PubMed
      35. Carter CC, Wagner GA, Hightower GK, Caballero G, Phung P, Richman D, Pond SL, Smith DM. HIV-1 neutralizing antibody response and viral genetic diversity characterized with next generation sequencing. Virology. 2015 Jan 1; 474:34-40. PMID: 25463602.
        View in: PubMed
      36. Cockerham LR, Siliciano JD, Sinclair E, O'Doherty U, Palmer S, Yukl SA, Strain MC, Chomont N, Hecht FM, Siliciano RF, Richman D, Deeks SG. CD4+ and CD8+ T Cell Activation Are Associated with HIV DNA in Resting CD4+ T Cells. PLoS One. 2014; 9(10):e110731. PMID: 25340755.
        View in: PubMed
      37. Hepler NL, Scheffler K, Weaver S, Murrell B, Richman D, Burton DR, Poignard P, Smith DM, Kosakovsky Pond SL. IDEPI: Rapid Prediction of HIV-1 Antibody Epitopes and Other Phenotypic Features from Sequence Data Using a Flexible Machine Learning Platform. PLoS Comput Biol. 2014 Sep; 10(9):e1003842. PMID: 25254639.
        View in: PubMed
      38. Menéndez-Arias L, Richman D. Editorial overview: antivirals and resistance: advances and challenges ahead. Curr Opin Virol. 2014 Oct; 8:iv-vii. PMID: 25155454.
        View in: PubMed
      39. Richman D. Joep MA Lange. Antivir Ther. 2014; 19(4):325-6. PMID: 25118622.
        View in: PubMed
      40. Kim EY, Lorenzo-Redondo R, Little SJ, Chung YS, Phalora PK, Maljkovic Berry I, Archer J, Penugonda S, Fischer W, Richman D, Bhattacharya T, Malim MH, Wolinsky SM. Human APOBEC3 Induced Mutation of Human Immunodeficiency Virus Type-1 Contributes to Adaptation and Evolution in Natural Infection. PLoS Pathog. 2014 Jul; 10(7):e1004281. PMID: 25080100.
        View in: PubMed
      41. Wang C, Abdel-Mohsen M, Strain MC, Lada SM, Yukl S, Cockerham LR, Pilcher CD, Hecht FM, Sinclair E, Liegler T, Richman D, Deeks SG, Pillai SK. Decreased HIV Type 1 Transcription in CCR5-?32 Heterozygotes During Suppressive Antiretroviral Therapy. J Infect Dis. 2014 Dec 1; 210(11):1838-43. PMID: 24935955.
        View in: PubMed
      42. Wensing AM, Calvez V, Günthard HF, Johnson VA, Paredes R, Pillay D, Shafer RW, Richman D. 2014 Update of the drug resistance mutations in HIV-1. Top Antivir Med. 2014 Jun-Jul; 22(3):642-50. PMID: 25101529.
        View in: PubMed
      43. Luzuriaga K, Tabak B, Garber M, Chen YH, Ziemniak C, McManus MM, Murray D, Strain MC, Richman D, Chun TW, Cunningham CK, Persaud D. HIV Type 1 (HIV-1) Proviral Reservoirs Decay Continuously Under Sustained Virologic Control in HIV-1-Infected Children Who Received Early Treatment. J Infect Dis. 2014 Nov 15; 210(10):1529-38. PMID: 24850788.
        View in: PubMed
      44. Gianella S, Massanella M, Richman D, Little SJ, Spina CA, Vargas MV, Lada SM, Daar ES, Dube MP, Haubrich RH, Morris SR, Smith DM. Cytomegalovirus Replication in Semen Is Associated with Higher Levels of Proviral HIV DNA and CD4+ T Cell Activation during Antiretroviral Treatment. J Virol. 2014 Jul 15; 88(14):7818-27. PMID: 24789781.
        View in: PubMed
      45. Karris MY, Kao YT, Patel D, Dawson M, Woods SP, Vaida F, Spina C, Richman D, Little S, Smith DM. Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection. AIDS. 2014 Mar 27; 28(6):841-9. PMID: 24401640.
        View in: PubMed
      46. Archin NM, Bateson R, Tripathy MK, Crooks AM, Yang KH, Dahl NP, Kearney MF, Anderson EM, Coffin JM, Strain MC, Richman D, Robertson KR, Kashuba AD, Bosch RJ, Hazuda DJ, Kuruc JD, Eron JJ, Margolis DM. HIV-1 Expression Within Resting CD4+ T Cells After Multiple Doses of Vorinostat. J Infect Dis. 2014 Sep 1; 210(5):728-35. PMID: 24620025.
        View in: PubMed
      47. Richman D. Editorial Commentary: Extending HIV Drug Resistance Testing to Low Levels of Plasma Viremia. Clin Infect Dis. 2014 Apr; 58(8):1174-5. PMID: 24429434.
        View in: PubMed
      48. Chaillon A, Gianella S, Wertheim JO, Richman D, Mehta SR, Smith DM. HIV Migration Between Blood and Cerebrospinal Fluid or Semen Over Time. J Infect Dis. 2014 May; 209(10):1642-52. PMID: 24302756.
        View in: PubMed
      49. Wagner GA, Pacold ME, Kosakovsky Pond SL, Caballero G, Chaillon A, Rudolph AE, Morris SR, Little SJ, Richman D, Smith DM. Incidence and Prevalence of Intrasubtype HIV-1 Dual Infection in At-Risk Men in the United States. J Infect Dis. 2014 Apr; 209(7):1032-8. PMID: 24273040.
        View in: PubMed
      50. Tatro ET, Purnajo I, Richman D, Smith DM, Gianella S, Litwin VM. Antibody Response to Achromobacter xylosoxidans during HIV Infection Is Associated with Lower CD4 Levels and Increased Lymphocyte Activation. Clin Vaccine Immunol. 2014 Jan; 21(1):46-50. PMID: 24173027.
        View in: PubMed
      51. Persaud D, Gay H, Ziemniak C, Chen YH, Piatak M, Chun TW, Strain M, Richman D, Luzuriaga K. Absence of detectable HIV-1 viremia after treatment cessation in an infant. N Engl J Med. 2013 Nov 7; 369(19):1828-35. PMID: 24152233.
        View in: PubMed
      52. Wertheim JO, Leigh Brown AJ, Hepler NL, Mehta SR, Richman D, Smith DM, Kosakovsky Pond SL. The Global Transmission Network of HIV-1. J Infect Dis. 2014 Jan; 209(2):304-13. PMID: 24151309.
        View in: PubMed
      53. Chaillon A, Gianella S, Vazquez H, Ignacio C, Zweig AC, Richman D, Smith DM. Novel Codon Insert in HIV Type 1 Clade B Reverse Transcriptase Associated with Low-Level Viremia During Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2014 Feb; 30(2):165-9. PMID: 24020934.
        View in: PubMed
      54. Chaillon A, Wagner GA, Hepler NL, Little SJ, Kosakovsky Pond SL, Caballero G, Pacold ME, Phung P, Wrin T, Richman D, Wertheim JO, Smith DM. Dynamics of Viral Evolution and Neutralizing Antibody Response after HIV-1 Superinfection. J Virol. 2013 Dec; 87(23):12737-44. PMID: 24049166.
        View in: PubMed
      55. Hatano H, Strain MC, Scherzer R, Bacchetti P, Wentworth D, Hoh R, Martin JN, McCune JM, Neaton JD, Tracy RP, Hsue PY, Richman D, Deeks SG. Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial. J Infect Dis. 2013 Nov 1; 208(9):1436-42. PMID: 23975885.
        View in: PubMed
      56. Gianella S, Morris SR, Tatro E, Vargas MV, Haubrich RH, Daar ES, Dube MP, Richman D, Little SJ, Smith DM. Virologic Correlates of Anti-CMV IgG Levels in HIV-1-Infected Men. J Infect Dis. 2014 Feb; 209(3):452-6. PMID: 23964106.
        View in: PubMed
      57. Massanella M, Singhania A, Beliakova-Bethell N, Pier R, Lada SM, White CH, Pérez-Santiago J, Blanco J, Richman D, Little SJ, Woelk CH. Differential gene expression in HIV-infected individuals following ART. Antiviral Res. 2013 Nov; 100(2):420-8. PMID: 23933117.
        View in: PubMed
      58. Pérez-Santiago J, Gianella S, Massanella M, Spina CA, Karris MY, Var SR, Patel D, Jordan PS, Young JA, Little SJ, Richman D, Smith DM. Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection. AIDS. 2013 Jul 31; 27(12):1921-31. PMID: 24180001.
        View in: PubMed
      59. Hightower GK, May SJ, Pérez-Santiago J, Pacold ME, Wagner GA, Little SJ, Richman D, Mehta SR, Smith DM, Pond SL. HIV-1 clade B pol evolution following primary infection. PLoS One. 2013; 8(6):e68188. PMID: 23840830.
        View in: PubMed
      60. Yukl SA, Boritz E, Busch M, Bentsen C, Chun TW, Douek D, Eisele E, Haase A, Ho YC, Hütter G, Justement JS, Keating S, Lee TH, Li P, Murray D, Palmer S, Pilcher C, Pillai S, Price RW, Rothenberger M, Schacker T, Siliciano J, Siliciano R, Sinclair E, Strain M, Wong J, Richman D, Deeks SG. Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient. PLoS Pathog. 2013; 9(5):e1003347. PMID: 23671416.
        View in: PubMed
      61. Rouzioux C, Richman D. How to best measure HIV reservoirs? Curr Opin HIV AIDS. 2013 May; 8(3):170-5. PMID: 23564004.
        View in: PubMed
      62. Wagner GA, Pacold ME, Vigil E, Caballero G, Morris SR, Kosakovsky Pond SL, Little SJ, Richman D, Gianella S, Smith DM. Using ultradeep pyrosequencing to study HIV-1 coreceptor usage in primary and dual infection. J Infect Dis. 2013 Jul 15; 208(2):271-4. PMID: 23599311.
        View in: PubMed
      63. Gianella S, Smith DM, Vargas MV, Little SJ, Richman D, Daar ES, Dube MP, Zhang F, Ginocchio CC, Haubrich RH, Morris SR. Shedding of HIV and human herpesviruses in the semen of effectively treated HIV-1-infected men who have sex with men. Clin Infect Dis. 2013 Aug; 57(3):441-7. PMID: 23595831.
        View in: PubMed
      64. Strain MC, Lada SM, Luong T, Rought SE, Gianella S, Terry VH, Spina CA, Woelk CH, Richman D. Highly precise measurement of HIV DNA by droplet digital PCR. PLoS One. 2013; 8(4):e55943. PMID: 23573183.
        View in: PubMed
      65. Katlama C, Deeks SG, Autran B, Martinez-Picado J, van Lunzen J, Rouzioux C, Miller M, Vella S, Schmitz JE, Ahlers J, Richman D, Sekaly RP. Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. Lancet. 2013 Jun 15; 381(9883):2109-17. PMID: 23541541.
        View in: PubMed
      66. Strain MC, Richman D. New assays for monitoring residual HIV burden in effectively treated individuals. Curr Opin HIV AIDS. 2013 Mar; 8(2):106-10. PMID: 23314907.
        View in: PubMed
      67. Eriksson S, Graf EH, Dahl V, Strain MC, Yukl SA, Lysenko ES, Bosch RJ, Lai J, Chioma S, Emad F, Abdel-Mohsen M, Hoh R, Hecht F, Hunt P, Somsouk M, Wong J, Johnston R, Siliciano RF, Richman D, O'Doherty U, Palmer S, Deeks SG, Siliciano JD. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog. 2013 Feb; 9(2):e1003174. PMID: 23459007.
        View in: PubMed
      68. Johnson VA, Calvez V, Gunthard HF, Paredes R, Pillay D, Shafer RW, Wensing AM, Richman D. Update of the drug resistance mutations in HIV-1: March 2013. Top Antivir Med. 2013 Feb-Mar; 21(1):6-14. PMID: 23596273.
        View in: PubMed
      69. Le T, Wright EJ, Smith DM, He W, Catano G, Okulicz JF, Young JA, Clark RA, Richman D, Little SJ, Ahuja SK. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med. 2013 Jan 17; 368(3):218-30. PMID: 23323898.
        View in: PubMed
      70. Beliakova-Bethell N, Zhang JX, Singhania A, Lee V, Terry VH, Richman D, Spina CA, Woelk CH. Suberoylanilide hydroxamic acid induces limited changes in the transcriptome of primary CD4(+) T cells. AIDS. 2013 Jan 2; 27(1):29-37. PMID: 23221426.
        View in: PubMed
      71. Gianella S, Morris SR, Anderson C, Spina CA, Vargas MV, Young JA, Richman D, Little SJ, Smith DM. Herpes viruses and HIV-1 drug resistance mutations influence the virologic and immunologic milieu of the male genital tract. AIDS. 2013 Jan 2; 27(1):39-47. PMID: 22739399.
        View in: PubMed
      72. Gianella S, Anderson CM, Vargas MV, Richman D, Little SJ, Morris SR, Smith DM. Cytomegalovirus DNA in semen and blood is associated with higher levels of proviral HIV DNA. J Infect Dis. 2013 Mar 15; 207(6):898-902. PMID: 23275608.
        View in: PubMed
      73. Gianella S, Morris SR, Vargas MV, Young JA, Callahan B, Richman D, Little SJ, Smith DM. Role of seminal shedding of herpesviruses in HIV Type 1 Transmission. J Infect Dis. 2013 Jan 15; 207(2):257-61. PMID: 23148284.
        View in: PubMed
      74. Gianella S, Mehta SR, Strain MC, Young JA, Vargas MV, Little SJ, Richman D, Kosakovsky Pond SL, Smith DM. Impact of seminal cytomegalovirus replication on HIV-1 dynamics between blood and semen. J Med Virol. 2012 Nov; 84(11):1703-9. PMID: 22997072.
        View in: PubMed
      75. Stadeli KM, Richman D. Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review. Antivir Ther. 2013; 18(1):115-23. PMID: 23052978.
        View in: PubMed
      76. Gianella S, Mehta SR, Young JA, Vargas MV, Little SJ, Richman D, Kosakovsky Pond SL, Smith DM. Sexual transmission of predicted CXCR4-tropic HIV-1 likely originating from the source partner's seminal cells. Virology. 2012 Dec 5; 434(1):2-4. PMID: 23040890.
        View in: PubMed
      77. Hightower GK, Wong JK, Letendre SL, Umlauf AA, Ellis RJ, Ignacio CC, Heaton RK, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Grant I, Little SJ, Richman D, Kosakovsky Pond SL, Smith DM. Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment. Virology. 2012 Nov 25; 433(2):498-505. PMID: 22999095.
        View in: PubMed
      78. Soto PC, Karris MY, Spina CA, Richman D, Varki A. Cell-intrinsic mechanism involving Siglec-5 associated with divergent outcomes of HIV-1 infection in human and chimpanzee CD4 T cells. J Mol Med (Berl). 2013 Feb; 91(2):261-70. PMID: 22945238.
        View in: PubMed
      79. Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, Cahn P, Eron JJ, Günthard HF, Hammer SM, Reiss P, Richman D, Rizzardini G, Thomas DL, Jacobsen DM, Volberding PA. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012 Jul 25; 308(4):387-402. PMID: 22820792.
        View in: PubMed
      80. Richman D. Antiretroviral drug resistance in resource-limited settings. Lancet. 2012 Oct 6; 380(9849):1210-1. PMID: 22828483.
        View in: PubMed
      81. Tilghman MW, May S, Pérez-Santiago J, Ignacio CC, Little SJ, Richman D, Smith DM. A combined screening platform for HIV treatment failure and resistance. PLoS One. 2012; 7(4):e35401. PMID: 22563383.
        View in: PubMed
      82. Choi JY, Hightower GK, Wong JK, Heaton R, Woods S, Grant I, Marcotte TD, Ellis RJ, Letendre SL, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Richman D, Smith DM. Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat. J Neurovirol. 2012 Apr; 18(2):81-90. PMID: 22528397.
        View in: PubMed
      83. Mehta SR, Kosakovsky Pond SL, Young JA, Richman D, Little S, Smith DM. Associations between phylogenetic clustering and HLA profile among HIV-infected individuals in San Diego, California. J Infect Dis. 2012 May 15; 205(10):1529-33. PMID: 22448013.
        View in: PubMed
      84. Agrawal A, DeSoto J, Fullagar JL, Maddali K, Rostami S, Richman D, Pommier Y, Cohen SM. Probing chelation motifs in HIV integrase inhibitors. Proc Natl Acad Sci U S A. 2012 Feb 14; 109(7):2251-6. PMID: 22308350.
        View in: PubMed
      85. Pacold ME, Pond SL, Wagner GA, Delport W, Bourque DL, Richman D, Little SJ, Smith DM. Clinical, virologic, and immunologic correlates of HIV-1 intraclade B dual infection among men who have sex with men. AIDS. 2012 Jan 14; 26(2):157-65. PMID: 22045341.
        View in: PubMed
      86. Gianella S, Strain MC, Rought SE, Vargas MV, Little SJ, Richman D, Spina CA, Smith DM. Associations between virologic and immunologic dynamics in blood and in the male genital tract. J Virol. 2012 Feb; 86(3):1307-15. PMID: 22114342.
        View in: PubMed
      87. Johnson VA, Calvez V, Günthard HF, Paredes R, Pillay D, Shafer R, Wensing AM, Richman D. 2011 update of the drug resistance mutations in HIV-1. Top Antivir Med. 2011 Nov; 19(4):156-64. PMID: 22156218.
        View in: PubMed
      88. Jeong J, Kim SR, Lee SH, Lim JH, Choi JI, Park JS, Chang CL, Choi JY, Richman D, Smith DM. The Use of High Performance Liquid Chromatography to Speciate and Characterize the Epidemiology of Mycobacteria. Lab Med. 2011 Oct 1; 42(10):612-617. PMID: 24443588.
        View in: PubMed
      89. Homann S, Smith D, Little S, Richman D, Guatelli J. Upregulation of BST-2/Tetherin by HIV infection in vivo. J Virol. 2011 Oct; 85(20):10659-68. PMID: 21849457.
        View in: PubMed
      90. Gianella S, Delport W, Pacold ME, Young JA, Choi JY, Little SJ, Richman D, Kosakovsky Pond SL, Smith DM. Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants. J Virol. 2011 Aug; 85(16):8359-67. PMID: 21632754.
        View in: PubMed
      91. Tilghman MW, Guerena DD, Licea A, Pérez-Santiago J, Richman D, May S, Smith DM. Pooled nucleic acid testing to detect antiretroviral treatment failure in Mexico. J Acquir Immune Defic Syndr. 2011 Mar 1; 56(3):e70-4. PMID: 21124228.
        View in: PubMed
      92. Meditz AL, MaWhinney S, Allshouse A, Feser W, Markowitz M, Little S, Hecht R, Daar ES, Collier AC, Margolick J, Kilby JM, Routy JP, Conway B, Kaldor J, Levy J, Schooley R, Cooper DA, Altfeld M, Richman D, Connick E. Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection. J Infect Dis. 2011 Feb 15; 203(4):442-51. PMID: 21245157.
        View in: PubMed
      93. Mascolini M, Mellors JW, Richman D, Boucher CA, Larder BA. HIV and hepatitis virus resistance to antivirals: review of data from the XIX International HIV and Hepatitis Virus Drug Resistance Workshop and curative strategies. Antivir Ther. 2011; 16(2):263-86. PMID: 21447877.
        View in: PubMed
      94. Richman D. Introduction: challenges to finding a cure for HIV infection. Curr Opin HIV AIDS. 2011 Jan; 6(1):1-3. PMID: 21242886.
        View in: PubMed
      95. Johnson VA, Brun-Vézinet F, Clotet B, Günthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman D. Update of the drug resistance mutations in HIV-1: December 2010. Top HIV Med. 2010 Dec; 18(5):156-63. PMID: 21245516.
        View in: PubMed
      96. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science. 2010 Dec 10; 330(6010):1551-7. PMID: 21051598.
        View in: PubMed
      97. Pacold M, Smith D, Little S, Cheng PM, Jordan P, Ignacio C, Richman D, Pond SK. Comparison of methods to detect HIV dual infection. AIDS Res Hum Retroviruses. 2010 Dec; 26(12):1291-8. PMID: 20954840.
        View in: PubMed
      98. Gianella S, Richman D. Minority variants of drug-resistant HIV. J Infect Dis. 2010 Sep 1; 202(5):657-66. PMID: 20649427.
        View in: PubMed
      99. Smith D, Delport W, Butler D, Little S, Richman D, Pond SK. Response to Comment on "The Origins of Sexually Transmitted HIV Among Men Who Have Sex with Men" Sci Transl Med. 2010 Sep; 2(50):501r1. PMID: 21532938.
        View in: PubMed
      100. Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, Gatell JM, Günthard HF, Hammer SM, Hirsch MS, Jacobsen DM, Reiss P, Richman D, Volberding PA, Yeni P, Schooley RT. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010 Jul 21; 304(3):321-33. PMID: 20639566.
        View in: PubMed
      101. Morris SR, Little SJ, Cunningham T, Garfein RS, Richman D, Smith DM. Evaluation of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results. Ann Intern Med. 2010 Jun 15; 152(12):778-85. PMID: 20547906.
        View in: PubMed
      102. Manosuthi W, Butler DM, Chantratita W, Sukasem C, Richman D, Smith DM. Patients infected with HIV type 1 subtype CRF01_AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine. AIDS Res Hum Retroviruses. 2010 Jun; 26(6):609-11. PMID: 20507208.
        View in: PubMed
      103. Markowitz M, Vaida F, Hare CB, Boden D, Mohri H, Hecht FM, Kalayjian RC, Conrad A, Mildvan D, Aberg J, Hogan C, Kilby JM, Balfour HH, Schafer K, Richman D, Little S. The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection. J Infect Dis. 2010 May 1; 201(9):1298-302. PMID: 20235838.
        View in: PubMed
      104. Goicoechea M, Jain S, Bi L, Kemper C, Daar ES, Diamond C, Ha B, Flaherty J, Sun S, Richman D, Louie S, Haubrich R. Abacavir and tenofovir disoproxil fumarate co-administration results in a nonadditive antiviral effect in HIV-1-infected patients. AIDS. 2010 Mar 13; 24(5):707-16. PMID: 20087154.
        View in: PubMed
      105. Butler DM, Delport W, Kosakovsky Pond SL, Lakdawala MK, Cheng PM, Little SJ, Richman D, Smith DM. The origins of sexually transmitted HIV among men who have sex with men. Sci Transl Med. 2010 Feb 10; 2(18):18re1. PMID: 20371483.
        View in: PubMed
      106. Manosuthi W, Butler DM, Pérez-Santiago J, Poon AF, Pillai SK, Mehta SR, Pacold ME, Richman D, Pond SK, Smith DM. Protease polymorphisms in HIV-1 subtype CRF01_AE represent selection by antiretroviral therapy and host immune pressure. AIDS. 2010 Jan 28; 24(3):411-6. PMID: 20009919.
        View in: PubMed
      107. Woelk CH, Beliakova-Bethell N, Goicoechea M, Zhao Y, Du P, Rought SE, Lozach J, Pérez-Santiago J, Richman D, Smith DM, Little SJ. Gene expression before HAART initiation predicts HIV-infected individuals at risk of poor CD4+ T-cell recovery. AIDS. 2010 Jan 16; 24(2):217-22. PMID: 19952713.
        View in: PubMed
      108. Goicoechea M, Jain S, Bi L, Sun S, Smith G, Ha B, Richman D, Louie S, Haubrich R. Interlaboratory measurement differences in intracellular carbovir triphosphate concentrations in HIV-infected patients: sources of variability in processing, shipping, and quantitation. J Clin Pharmacol. 2010 Aug; 50(8):968-74. PMID: 19952374.
        View in: PubMed
      109. Johnson VA, Brun-Vezinet F, Clotet B, Gunthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman D. Update of the drug resistance mutations in HIV-1: December 2009. Top HIV Med. 2009 Dec; 17(5):138-45. PMID: 20068260.
        View in: PubMed
      110. Smith DM, May SJ, Pérez-Santiago J, Strain MC, Ignacio CC, Haubrich RH, Richman D, Benson CA, Little SJ. The use of pooled viral load testing to identify antiretroviral treatment failure. AIDS. 2009 Oct 23; 23(16):2151-8. PMID: 19730348.
        View in: PubMed
      111. Hightower GK, Letendre SL, Cherner M, Gibson SA, Ellis RJ, Wolfson TJ, Gamst AC, Ignacio CC, Heaton RK, Grant I, Richman D, Smith DM. Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance. Virology. 2009 Nov 25; 394(2):243-8. PMID: 19762060.
        View in: PubMed
      112. Butler DM, Pacold ME, Jordan PS, Richman D, Smith DM. The efficiency of single genome amplification and sequencing is improved by quantitation and use of a bioinformatics tool. J Virol Methods. 2009 Dec; 162(1-2):280-3. PMID: 19698751.
        View in: PubMed
      113. Jordan PS, Poon A, Eron J, Squires K, Ignacio C, Richman D, Smith DM. A novel codon insert in protease of clade B HIV type 1. AIDS Res Hum Retroviruses. 2009 May; 25(5):547-50. PMID: 19397401.
        View in: PubMed
      114. Eron JJ, Park JG, Haubrich R, Aweeka F, Bastow B, Pakes GE, Yu S, Wu H, Richman D. Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy. Antimicrob Agents Chemother. 2009 Jun; 53(6):2335-41. PMID: 19307363.
        View in: PubMed
      115. Richman D, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. The challenge of finding a cure for HIV infection. Science. 2009 Mar 6; 323(5919):1304-7. PMID: 19265012.
        View in: PubMed
      116. Yukl S, Pillai S, Li P, Chang K, Pasutti W, Ahlgren C, Havlir D, Strain M, Günthard H, Richman D, Rice AP, Daar E, Little S, Wong JK. Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity. Virology. 2009 Apr 25; 387(1):98-108. PMID: 19268337.
        View in: PubMed
      117. Smith DM, May SJ, Tweeten S, Drumright L, Pacold ME, Kosakovsky Pond SL, Pesano RL, Lie YS, Richman D, Frost SD, Woelk CH, Little SJ. A public health model for the molecular surveillance of HIV transmission in San Diego, California. AIDS. 2009 Jan 14; 23(2):225-32. PMID: 19098493.
        View in: PubMed
      118. Mascolini M, Boucher CA, Mellors JW, Larder BA, Richman D. Progress in basic and clinical research on HIV resistance: report on the XVIII International HIV Drug Resistance Workshop. Antivir Ther. 2009; 14(7):1015-37. PMID: 19918107.
        View in: PubMed
      119. Smith DM, Zárate S, Shao H, Pillai SK, Letendre SL, Wong JK, Richman D, Frost SD, Ellis RJ. Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations. Virology. 2009 Mar 1; 385(1):204-8. PMID: 19100592.
        View in: PubMed
      120. Johnson VA, Brun-Vezinet F, Clotet B, Gunthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman D. Update of the Drug Resistance Mutations in HIV-1. Top HIV Med. 2008 Dec; 16(5):138-45. PMID: 19106428.
        View in: PubMed
      121. Precopio ML, Butterfield TR, Casazza JP, Little SJ, Richman D, Koup RA, Roederer M. Optimizing peptide matrices for identifying T-cell antigens. Cytometry A. 2008 Nov; 73(11):1071-8. PMID: 18781655.
        View in: PubMed
      122. Binley JM, Lybarger EA, Crooks ET, Seaman MS, Gray E, Davis KL, Decker JM, Wycuff D, Harris L, Hawkins N, Wood B, Nathe C, Richman D, Tomaras GD, Bibollet-Ruche F, Robinson JE, Morris L, Shaw GM, Montefiori DC, Mascola JR. Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C. J Virol. 2008 Dec; 82(23):11651-68. PMID: 18815292.
        View in: PubMed
      123. Butler DM, Smith DM, Cachay ER, Hightower GK, Nugent CT, Richman D, Little SJ. Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men. AIDS. 2008 Aug 20; 22(13):1667-71. PMID: 18670228.
        View in: PubMed
      124. Hammer SM, Eron JJ, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman D, Yeni PG, Volberding PA. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008 Aug 6; 300(5):555-70. PMID: 18677028.
        View in: PubMed
      125. Hirsch MS, Günthard HF, Schapiro JM, Brun-Vézinet F, Clotet B, Hammer SM, Johnson VA, Kuritzkes DR, Mellors JW, Pillay D, Yeni PG, Jacobsen DM, Richman D. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Top HIV Med. 2008 Aug-Sep; 16(3):266-85. PMID: 19856548.
        View in: PubMed
      126. Grant RM, Hamer D, Hope T, Johnston R, Lange J, Lederman MM, Lieberman J, Miller CJ, Moore JP, Mosier DE, Richman D, Schooley RT, Springer MS, Veazey RS, Wainberg MA. Whither or wither microbicides? Science. 2008 Jul 25; 321(5888):532-4. PMID: 18653884.
        View in: PubMed
      127. Hirsch MS, Günthard HF, Schapiro JM, Brun-Vézinet F, Clotet B, Hammer SM, Johnson VA, Kuritzkes DR, Mellors JW, Pillay D, Yeni PG, Jacobsen DM, Richman D. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin Infect Dis. 2008 Jul 15; 47(2):266-85. PMID: 18549313.
        View in: PubMed
      128. Nelson JD, Kinkead H, Brunel FM, Leaman D, Jensen R, Louis JM, Maruyama T, Bewley CA, Bowdish K, Clore GM, Dawson PE, Frederickson S, Mage RG, Richman D, Burton DR, Zwick MB. Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics. Virology. 2008 Jul 20; 377(1):170-83. PMID: 18499210.
        View in: PubMed
      129. Liu L, May S, Richman D, Hecht FM, Markowitz M, Daar ES, Routy JP, Margolick JB, Collier AC, Woelk CH, Little SJ, Smith DM. Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance. AIDS. 2008 Apr 23; 22(7):835-9. PMID: 18427201.
        View in: PubMed
      130. Cachay ER, Frost SD, Poon AF, Looney D, Rostami SM, Pacold ME, Richman D, Little SJ, Smith DM. Herpes simplex virus type 2 acquisition during recent HIV infection does not influence plasma HIV levels. J Acquir Immune Defic Syndr. 2008 Apr 15; 47(5):592-6. PMID: 18197122.
        View in: PubMed
      131. Johnson VA, Brun-Vezinet F, Clotet B, Günthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman D. Update of the drug resistance mutations in HIV-1: Spring 2008. Top HIV Med. 2008 Apr-May; 16(1):62-8. PMID: 18441382.
        View in: PubMed
      132. Ahuja SK, Kulkarni H, Catano G, Agan BK, Camargo JF, He W, O'Connell RJ, Marconi VC, Delmar J, Eron J, Clark RA, Frost S, Martin J, Ahuja SS, Deeks SG, Little S, Richman D, Hecht FM, Dolan MJ. CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals. Nat Med. 2008 Apr; 14(4):413-20. PMID: 18376407.
        View in: PubMed
      133. Little SJ, Frost SD, Wong JK, Smith DM, Pond SL, Ignacio CC, Parkin NT, Petropoulos CJ, Richman D. Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. J Virol. 2008 Jun; 82(11):5510-8. PMID: 18353964.
        View in: PubMed
      134. Koelsch KK, Liu L, Haubrich R, May S, Havlir D, Günthard HF, Ignacio CC, Campos-Soto P, Little SJ, Shafer R, Robbins GK, D'Aquila RT, Kawano Y, Young K, Dao P, Spina CA, Richman D, Wong JK. Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro. J Infect Dis. 2008 Feb 1; 197(3):411-9. PMID: 18248304.
        View in: PubMed
      135. Mascolini M, Richman D, Larder B, Mellors J, Boucher CA. Clinical implications of resistance to antiretrovirals: new resistance technologies and interpretations. Antivir Ther. 2008; 13(2):319-34. PMID: 18505183.
        View in: PubMed
      136. Mascolini M, Larder BA, Boucher CA, Richman D, Mellors JW. Broad advances in understanding HIV resistance to antiretrovirals: report on the XVII International HIV Drug Resistance Workshop. Antivir Ther. 2008; 13(8):1097-113. PMID: 19195337.
        View in: PubMed
      137. Frost SD, Trkola A, Günthard HF, Richman D. Antibody responses in primary HIV-1 infection. Curr Opin HIV AIDS. 2008 Jan; 3(1):45-51. PMID: 19372943.
        View in: PubMed
      138. Poon AF, Kosakovsky Pond SL, Richman D, Frost SD. Mapping protease inhibitor resistance to human immunodeficiency virus type 1 sequence polymorphisms within patients. J Virol. 2007 Dec; 81(24):13598-607. PMID: 17913806.
        View in: PubMed
      139. Johnson VA, Brun-Vézinet F, Clotet B, Günthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman D. Update of the drug resistance mutations in HIV-1: 2007. Top HIV Med. 2007 Aug-Sep; 15(4):119-25. PMID: 17720996.
        View in: PubMed
      140. Smith DM, Wong JK, Shao H, Hightower GK, Mai SH, Moreno JM, Ignacio CC, Frost SD, Richman D, Little SJ. Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission. J Infect Dis. 2007 Aug 1; 196(3):356-60. PMID: 17597449.
        View in: PubMed
      141. Dhillon AK, Donners H, Pantophlet R, Johnson WE, Decker JM, Shaw GM, Lee FH, Richman D, Doms RW, Vanham G, Burton DR. Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors. J Virol. 2007 Jun; 81(12):6548-62. PMID: 17409160.
        View in: PubMed
      142. Woelk CH, Frost SD, Richman D, Higley PE, Kosakovsky Pond SL. Evolution of the interferon alpha gene family in eutherian mammals. Gene. 2007 Aug 1; 397(1-2):38-50. PMID: 17512142.
        View in: PubMed
      143. Cachay ER, Frost SD, Richman D, Smith DM, Little SJ. Herpes simplex virus type 2 infection does not influence viral dynamics during early HIV-1 infection. J Infect Dis. 2007 May 1; 195(9):1270-7. PMID: 17396995.
        View in: PubMed
      144. Poon AF, Kosakovsky Pond SL, Bennett P, Richman D, Leigh Brown AJ, Frost SD. Adaptation to human populations is revealed by within-host polymorphisms in HIV-1 and hepatitis C virus. PLoS Pathog. 2007 Mar; 3(3):e45. PMID: 17397261.
        View in: PubMed
      145. Mascolini M, Boucher C, Larder B, Mellors J, Richman D. Key reports from the XV International HIV Drug Resistance Workshop 2006. Antivir Ther. 2007; 12(1):131-45. PMID: 17503758.
        View in: PubMed
      146. Richman D. Advances in the management of HIV-HBV coinfection. Antivir Ther. 2007; 12 Suppl 3:H1. PMID: 18284177.
        View in: PubMed
      147. Smith D, Moini N, Pesano R, Cachay E, Aiem H, Lie Y, Richman D, Little S. Clinical utility of HIV standard genotyping among antiretroviral-naive individuals with unknown duration of infection. Clin Infect Dis. 2007 Feb 1; 44(3):456-8. PMID: 17205459.
        View in: PubMed
      148. Ahuja SK, Aiuti F, Berkhout B, Biberfeld P, Burton DR, Colizzi V, Deeks SG, Desrosiers RC, Dierich MP, Doms RW, Emerman M, Gallo RC, Girard M, Greene WC, Hoxie JA, Hunter E, Klein G, Korber B, Kuritzkes DR, Lederman MM, Malim MH, Marx PA, McCune JM, McMichael A, Miller C, Miller V, Montagnier L, Montefiori DC, Moore JP, Nixon DF, Overbaugh J, Pauza CD, Richman D, Saag MS, Sattentau Q, Schooley RT, Shattock R, Shaw GM, Stevenson M, Trkola A, Wainberg MA, Weiss RA, Wolinsky S, Zack JA. A plea for justice for jailed medical workers. Science. 2006 Nov 10; 314(5801):924-5. PMID: 17062652.
        View in: PubMed
      149. Smith DM, Strain MC, Frost SD, Pillai SK, Wong JK, Wrin T, Liu Y, Petropolous CJ, Daar ES, Little SJ, Richman D. Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. Virology. 2006 Nov 10; 355(1):1-5. PMID: 16962152.
        View in: PubMed
      150. Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman D, Vella S, Yeni PG, Volberding PA. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA. 2006 Aug 16; 296(7):827-43. PMID: 16905788.
        View in: PubMed
      151. Johnson VA, Brun-Vezinet F, Clotet B, Kuritzkes DR, Pillay D, Schapiro JM, Richman D. Update of the drug resistance mutations in HIV-1: Fall 2006. Top HIV Med. 2006 Aug-Sep; 14(3):125-30. PMID: 16946457.
        View in: PubMed
      152. Day JR, Martínez LE, Sásik R, Hitchin DL, Dueck ME, Richman D, Guatelli JC. A computer-based, image-analysis method to quantify HIV-1 infection in a single-cycle infectious center assay. J Virol Methods. 2006 Oct; 137(1):125-33. PMID: 16876264.
        View in: PubMed
      153. Pond SL, Frost SD, Grossman Z, Gravenor MB, Richman D, Brown AJ. Adaptation to different human populations by HIV-1 revealed by codon-based analyses. PLoS Comput Biol. 2006 Jun 23; 2(6):e62. PMID: 16789820.
        View in: PubMed
      154. Pillai SK, Pond SL, Liu Y, Good BM, Strain MC, Ellis RJ, Letendre S, Smith DM, Günthard HF, Grant I, Marcotte TD, McCutchan JA, Richman D, Wong JK. Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain. 2006 Jul; 129(Pt 7):1872-83. PMID: 16735456.
        View in: PubMed
      155. Richman D. Antiviral drug resistance. Antiviral Res. 2006 Sep; 71(2-3):117-21. PMID: 16621040.
        View in: PubMed
      156. Yuste E, Sanford HB, Carmody J, Bixby J, Little S, Zwick MB, Greenough T, Burton DR, Richman D, Desrosiers RC, Johnson WE. Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma. J Virol. 2006 Mar; 80(6):3030-41. PMID: 16501112.
        View in: PubMed
      157. Boucher C, Larder B, Mellors J, Richman D. The XIVth International HIV Drug Resistance Workshop, Quebec City, Canada, June 2005. Antivir Ther. 2006; 11(5):653-65. PMID: 16964836.
        View in: PubMed
      158. Frost SD, Wrin T, Smith DM, Kosakovsky Pond SL, Liu Y, Paxinos E, Chappey C, Galovich J, Beauchaine J, Petropoulos CJ, Little SJ, Richman D. Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc Natl Acad Sci U S A. 2005 Dec 20; 102(51):18514-9. PMID: 16339909.
        View in: PubMed
      159. Johnson VA, Brun-Vezinet F, Clotet B, Conway B, Kuritzkes DR, Pillay D, Schapiro JM, Telenti A, Richman D. Update of the drug resistance mutations in HIV-1: Fall 2005. Top HIV Med. 2005 Oct-Nov; 13(4):125-31. PMID: 16304457.
        View in: PubMed
      160. Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Petropoulos CJ, Richman D, Little SJ. HIV drug resistance acquired through superinfection. AIDS. 2005 Aug 12; 19(12):1251-6. PMID: 16052079.
        View in: PubMed
      161. Lehrman G, Hogue IB, Palmer S, Jennings C, Spina CA, Wiegand A, Landay AL, Coombs RW, Richman D, Mellors JW, Coffin JM, Bosch RJ, Margolis DM. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet. 2005 Aug 13-19; 366(9485):549-55. PMID: 16099290.
        View in: PubMed
      162. Smith DM, Richman D, Little SJ. HIV superinfection. J Infect Dis. 2005 Aug 1; 192(3):438-44. PMID: 15995957.
        View in: PubMed
      163. Pillai SK, Kosakovsky Pond SL, Woelk CH, Richman D, Smith DM. Codon volatility does not reflect selective pressure on the HIV-1 genome. Virology. 2005 Jun 5; 336(2):137-43. PMID: 15892955.
        View in: PubMed
      164. Zolopa AR, Lazzeroni LC, Rinehart A, Vezinet FB, Clavel F, Collier A, Conway B, Gulick RM, Holodniy M, Perno CF, Shafer RW, Richman D, Wainberg MA, Kuritzkes DR. Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: an international comparison (The GUESS Study). Clin Infect Dis. 2005 Jul 1; 41(1):92-9. PMID: 15937768.
        View in: PubMed
      165. Frost SD, Liu Y, Pond SL, Chappey C, Wrin T, Petropoulos CJ, Little SJ, Richman D. Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B. J Virol. 2005 May; 79(10):6523-7. PMID: 15858036.
        View in: PubMed
      166. Daar ES, Richman D. Confronting the emergence of drug-resistant HIV type 1: impact of antiretroviral therapy on individual and population resistance. AIDS Res Hum Retroviruses. 2005 May; 21(5):343-57. PMID: 15929696.
        View in: PubMed
      167. Strain MC, Little SJ, Daar ES, Havlir DV, Gunthard HF, Lam RY, Daly OA, Nguyen J, Ignacio CC, Spina CA, Richman D, Wong JK. Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. J Infect Dis. 2005 May 1; 191(9):1410-8. PMID: 15809898.
        View in: PubMed
      168. Johnson VA, Brun-Vezinet F, Clotet B, Conway B, Kuritzkes DR, Pillay D, Schapiro J, Telenti A, Richman D. Update of the Drug Resistance Mutations in HIV-1: 2005. Top HIV Med. 2005 Mar-Apr; 13(1):51-7. PMID: 15849371.
        View in: PubMed
      169. Haubrich RH, Kemper CA, Hellmann NS, Keiser PH, Witt MD, Tilles JG, Forthal DN, Leedom J, Leibowitz M, McCutchan JA, Richman D. A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy: CCTG 575. AIDS. 2005 Feb 18; 19(3):295-302. PMID: 15718840.
        View in: PubMed
      170. Pillai SK, Good B, Pond SK, Wong JK, Strain MC, Richman D, Smith DM. Semen-specific genetic characteristics of human immunodeficiency virus type 1 env. J Virol. 2005 Feb; 79(3):1734-42. PMID: 15650198.
        View in: PubMed
      171. Yang OO, Daar ES, Jamieson BD, Balamurugan A, Smith DM, Pitt JA, Petropoulos CJ, Richman D, Little SJ, Brown AJ. Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains. J Virol. 2005 Jan; 79(2):860-8. PMID: 15613314.
        View in: PubMed
      172. Crooks ET, Moore PL, Richman D, Robinson J, Crooks JA, Franti M, Schülke N, Binley JM. Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization. Hum Antibodies. 2005; 14(3-4):101-13. PMID: 16720980.
        View in: PubMed
      173. Dong T, Stewart-Jones G, Chen N, Easterbrook P, Xu X, Papagno L, Appay V, Weekes M, Conlon C, Spina C, Little S, Screaton G, van der Merwe A, Richman D, McMichael AJ, Jones EY, Rowland-Jones SL. HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J Exp Med. 2004 Dec 20; 200(12):1547-57. PMID: 15596521.
        View in: PubMed
      174. Woelk CH, Ottones F, Plotkin CR, Du P, Royer CD, Rought SE, Lozach J, Sasik R, Kornbluth RS, Richman D, Corbeil J. Interferon gene expression following HIV type 1 infection of monocyte-derived macrophages. AIDS Res Hum Retroviruses. 2004 Nov; 20(11):1210-22. PMID: 15588343.
        View in: PubMed
      175. Johnson VA, Brun-Vézinet F, Clotet B, Conway B, D'Aquila RT, Demeter LM, Kuritzkes DR, Pillay D, Schapiro JM, Telenti A, Richman D. Update of the drug resistance mutations in HIV-1: 2004. Top HIV Med. 2004 Oct-Nov; 12(4):119-24. PMID: 15516709.
        View in: PubMed
      176. Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Daar ES, Richman D, Little SJ. Incidence of HIV superinfection following primary infection. JAMA. 2004 Sep 8; 292(10):1177-8. PMID: 15353529.
        View in: PubMed
      177. Smith DM, Kingery JD, Wong JK, Ignacio CC, Richman D, Little SJ. The prostate as a reservoir for HIV-1. AIDS. 2004 Jul 23; 18(11):1600-2. PMID: 15238781.
        View in: PubMed
      178. Yeni PG, Hammer SM, Hirsch MS, Saag MS, Schechter M, Carpenter CC, Fischl MA, Gatell JM, Gazzard BG, Jacobsen DM, Katzenstein DA, Montaner JS, Richman D, Schooley RT, Thompson MA, Vella S, Volberding PA. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA. 2004 Jul 14; 292(2):251-65. PMID: 15249575.
        View in: PubMed
      179. Richman D, Morton SC, Wrin T, Hellmann N, Berry S, Shapiro MF, Bozzette SA. The prevalence of antiretroviral drug resistance in the United States. AIDS. 2004 Jul 2; 18(10):1393-401. PMID: 15199315.
        View in: PubMed
      180. Yu Q, König R, Pillai S, Chiles K, Kearney M, Palmer S, Richman D, Coffin JM, Landau NR. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat Struct Mol Biol. 2004 May; 11(5):435-42. PMID: 15098018.
        View in: PubMed
      181. Richman D. Benefits and limitations of testing for resistance to HIV drugs. J Antimicrob Chemother. 2004 Apr; 53(4):555-7. PMID: 15014064.
        View in: PubMed
      182. Leigh Brown AJ, Frost SD, Good B, Daar ES, Simon V, Markowitz M, Collier AC, Connick E, Conway B, Margolick JB, Routy JP, Corbeil J, Hellmann NS, Richman D, Little SJ. Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection. J Virol. 2004 Mar; 78(5):2242-6. PMID: 14963120.
        View in: PubMed
      183. Papagno L, Spina CA, Marchant A, Salio M, Rufer N, Little S, Dong T, Chesney G, Waters A, Easterbrook P, Dunbar PR, Shepherd D, Cerundolo V, Emery V, Griffiths P, Conlon C, McMichael AJ, Richman D, Rowland-Jones SL, Appay V. Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol. 2004 Feb; 2(2):E20. PMID: 14966528.
        View in: PubMed
      184. Richman D, Little SJ, Smith DM, Wrin T, Petropoulos C, Wong JK. HIV evolution and escape. Trans Am Clin Climatol Assoc. 2004; 115:289-303. PMID: 17060974.
        View in: PubMed
      185. Gallant JE, Gerondelis PZ, Wainberg MA, Shulman NS, Haubrich RH, St Clair M, Lanier ER, Hellmann NS, Richman D. Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistance. Antivir Ther. 2003 Dec; 8(6):489-506. PMID: 14760883.
        View in: PubMed
      186. Gulick RM, Meibohm A, Havlir D, Eron JJ, Mosley A, Chodakewitz JA, Isaacs R, Gonzalez C, McMahon D, Richman D, Robertson M, Mellors JW. Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine. AIDS. 2003 Nov 7; 17(16):2345-9. PMID: 14571186.
        View in: PubMed
      187. Johnson VA, Brun-Vézinet F, Clotet B, Conway B, D'Aquila RT, Demeter LM, Kuritzkes DR, Pillay D, Schapiro JM, Telenti A, Richman D. Drug resistance mutations in HIV-1. Top HIV Med. 2003 Nov-Dec; 11(6):215-21. PMID: 14724329.
        View in: PubMed
      188. Ali A, Pillai S, Ng H, Lubong R, Richman D, Jamieson BD, Ding Y, McElrath MJ, Guatelli JC, Yang OO. Broadly increased sensitivity to cytotoxic T lymphocytes resulting from Nef epitope escape mutations. J Immunol. 2003 Oct 15; 171(8):3999-4005. PMID: 14530319.
        View in: PubMed
      189. Hirsch MS, Brun-Vézinet F, Clotet B, Conway B, Kuritzkes DR, D'Aquila RT, Demeter LM, Hammer SM, Johnson VA, Loveday C, Mellors JW, Richman D. Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel. Top HIV Med. 2003 Jul-Aug; 11(4):150-4. PMID: 12876334.
        View in: PubMed
      190. Hirsch MS, Brun-Vézinet F, Clotet B, Conway B, Kuritzkes DR, D'Aquila RT, Demeter LM, Hammer SM, Johnson VA, Loveday C, Mellors JW, Jacobsen DM, Richman D. Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel. Clin Infect Dis. 2003 Jul 1; 37(1):113-28. PMID: 12830416.
        View in: PubMed
      191. Zaunders JJ, Moutouh-de Parseval L, Kitada S, Reed JC, Rought S, Genini D, Leoni L, Kelleher A, Cooper DA, Smith DE, Grey P, Estaquier J, Little S, Richman D, Corbeil J. Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2. J Infect Dis. 2003 Jun 1; 187(11):1735-47. PMID: 12751031.
        View in: PubMed
      192. Koelsch KK, Smith DM, Little SJ, Ignacio CC, Macaranas TR, Brown AJ, Petropoulos CJ, Richman D, Wong JK. Clade B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus. AIDS. 2003 May 2; 17(7):F11-6. PMID: 12700477.
        View in: PubMed
      193. D'Aquila RT, Schapiro JM, Brun-Vézinet F, Clotet B, Conway B, Demeter LM, Grant RM, Johnson VA, Kuritzkes DR, Loveday C, Shafer RW, Richman D. Drug resistance mutations in HIV-1. Top HIV Med. 2003 May-Jun; 11(3):92-6. PMID: 12837968.
        View in: PubMed
      194. Richman D, Wrin T, Little SJ, Petropoulos CJ. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci U S A. 2003 Apr 1; 100(7):4144-9. PMID: 12644702.
        View in: PubMed
      195. Sheeter D, Du P, Rought S, Richman D, Corbeil J. Surface CD4 expression modulated by a cellular factor induced by HIV type 1 infection. AIDS Res Hum Retroviruses. 2003 Feb; 19(2):117-23. PMID: 12639247.
        View in: PubMed
      196. Pillai S, Good B, Richman D, Corbeil J. A new perspective on V3 phenotype prediction. AIDS Res Hum Retroviruses. 2003 Feb; 19(2):145-9. PMID: 12643277.
        View in: PubMed
      197. Leigh Brown AJ, Frost SD, Mathews WC, Dawson K, Hellmann NS, Daar ES, Richman D, Little SJ. Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population. J Infect Dis. 2003 Feb 15; 187(4):683-6. PMID: 12599087.
        View in: PubMed
      198. Anton PA, Mitsuyasu RT, Deeks SG, Scadden DT, Wagner B, Huang C, Macken C, Richman D, Christopherson C, Borellini F, Lazar R, Hege KM. Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects. AIDS. 2003 Jan 3; 17(1):53-63. PMID: 12478069.
        View in: PubMed
      199. Uckun FM, Pendergrass S, Venkatachalam TK, Qazi S, Richman D. Stampidine is a potent inhibitor of Zidovudine- and nucleoside analog reverse transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutations. Antimicrob Agents Chemother. 2002 Nov; 46(11):3613-6. PMID: 12384373.
        View in: PubMed
      200. Haubrich RH, Kemper CA, Hellmann NS, Keiser PH, Witt MD, Forthal DN, Leedom J, Leibowitz M, Whitcomb JM, Richman D, McCutchan JA. The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis. AIDS. 2002 Oct 18; 16(15):F33-40. PMID: 12370520.
        View in: PubMed
      201. Bennett KK, DeGruttola VG, Marschner IC, Havlir DV, Richman D. Baseline predictors of CD4 T-lymphocyte recovery with combination antiretroviral therapy. J Acquir Immune Defic Syndr. 2002 Sep 1; 31(1):20-6. PMID: 12352146.
        View in: PubMed
      202. Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, Koup RA, Mellors JW, Connick E, Conway B, Kilby M, Wang L, Whitcomb JM, Hellmann NS, Richman D. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med. 2002 Aug 8; 347(6):385-94. PMID: 12167680.
        View in: PubMed
      203. Yeni PG, Hammer SM, Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman D, Saag MS, Schechter M, Schooley RT, Thompson MA, Vella S, Volberding PA. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA. 2002 Jul 10; 288(2):222-35. PMID: 12095387.
        View in: PubMed
      204. Estaquier J, Lelièvre JD, Petit F, Brunner T, Moutouh-De Parseval L, Richman D, Ameisen JC, Corbeil J. Effects of antiretroviral drugs on human immunodeficiency virus type 1-induced CD4(+) T-cell death. J Virol. 2002 Jun; 76(12):5966-73. PMID: 12021329.
        View in: PubMed
      205. Deeks SG, Wagner B, Anton PA, Mitsuyasu RT, Scadden DT, Huang C, Macken C, Richman D, Christopherson C, June CH, Lazar R, Broad DF, Jalali S, Hege KM. A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy. Mol Ther. 2002 Jun; 5(6):788-97. PMID: 12027564.
        View in: PubMed
      206. Appay V, Papagno L, Spina CA, Hansasuta P, King A, Jones L, Ogg GS, Little S, McMichael AJ, Richman D, Rowland-Jones SL. Dynamics of T cell responses in HIV infection. J Immunol. 2002 Apr 1; 168(7):3660-6. PMID: 11907132.
        View in: PubMed
      207. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, Ogg GS, King A, Lechner F, Spina CA, Little S, Havlir DV, Richman D, Gruener N, Pape G, Waters A, Easterbrook P, Salio M, Cerundolo V, McMichael AJ, Rowland-Jones SL. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med. 2002 Apr; 8(4):379-85. PMID: 11927944.
        View in: PubMed
      208. Appay V, Hansasuta P, Sutton J, Schrier RD, Wong JK, Furtado M, Havlir DV, Wolinsky SM, McMichael AJ, Richman D, Rowland-Jones SL, Spina CA. Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression. AIDS. 2002 Jan 25; 16(2):161-70. PMID: 11807299.
        View in: PubMed
      209. Casimiro DR, Tang A, Perry HC, Long RS, Chen M, Heidecker GJ, Davies ME, Freed DC, Persaud NV, Dubey S, Smith JG, Havlir D, Richman D, Chastain MA, Simon AJ, Fu TM, Emini EA, Shiver JW. Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene. J Virol. 2002 Jan; 76(1):185-94. PMID: 11739684.
        View in: PubMed
      210. Richman D. Antiretroviral activity of emtricitabine, a potent nucleoside reverse transcriptase inhibitor. Antivir Ther. 2001 Jun; 6(2):83-8. PMID: 11491420.
        View in: PubMed
      211. Richman D. HIV chemotherapy. Nature. 2001 Apr 19; 410(6831):995-1001. PMID: 11309630.
        View in: PubMed
      212. Richman D. Normal physiology and HIV pathophysiology of human T-cell dynamics. J Clin Invest. 2000 Mar; 105(5):565-6. PMID: 10712427.
        View in: PubMed
      213. Richman D. Principles of HIV resistance testing and overview of assay performance characteristics. Antivir Ther. 2000 Mar; 5(1):27-31. PMID: 10846590.
        View in: PubMed
      214. Richman D. The implications of drug resistance for strategies of combination antiviral chemotherapy. Antiviral Res. 1996 Jan; 29(1):31-3. PMID: 8721540.
        View in: PubMed
      Douglas's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department
      Physical Neighbors
      People whose addresses are nearby this person.
      _